title: Does prior infection with varicella-zoster virus influence risk of adult glioma?
abstract: To evaluate a possible association between varicella-zoster virus infection and glioma, the authors asked adults with glioma (n = 462) whose tumors were diagnosed between August 1, 1991, and March 31, 1994, and age-, sex-, and ethnicity-matched controls (n = 443) about their histories of chickenpox or shingles. Cases were significantly less likely than controls to report a history of either chickenpox (odds ratio = 0.4, 95% confidence interval (CI) 0.3-0.6) or shingles (odds ratio = 0.5, 95% CI 0.3-0.8). To obtain serologic support for these findings, the authors conducted double-blind enzyme-linked immunosorbent assays for immunoglobulin G antibodies to varicella-zoster virus among 167 self-reporting subjects for whom blood samples were available. Cases and controls reporting no history of chickenpox were equally likely to test positive (73% vs. 75%), but among those reporting a positive history, cases were less likely than were controls to test positive (71% vs. 85%). Despite the misclassification, an odds ratio of 0.6 was obtained using either serologic data (95% CI 0.3-1.3) or reported history of chickenpox (95% CI 0.3-1.1) in this subgroup of subjects. This suggests that adults with glioma were less likely than controls either to have had prior varicella-zoster virus infection or to have an immunoglobulin G antibody response adequate to indicate positivity. Since either explanation suggests novel mechanisms for brain tumor pathogenesis, these findings require corroboration and elaboration.
authors.affiliation: Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco 94143-0560, USA.
authors.forename: M
authors.initials: M
authors.lastname: Wrensch
authors.forename: A
authors.initials: A
authors.lastname: Weinberg
authors.forename: J
authors.initials: J
authors.lastname: Wiencke
authors.forename: H
authors.initials: H
authors.lastname: Masters
authors.forename: R
authors.initials: R
authors.lastname: Miike
authors.forename: G
authors.initials: G
authors.lastname: Barger
authors.forename: M
authors.initials: M
authors.lastname: Lee
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D001932:Brain Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D002140:California / Q000453:epidemiology; D016022:Case-Control Studies; D002644:Chickenpox / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D005260:Female; D005910:Glioma / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D006562:Herpes Zoster / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D016017:Odds Ratio; D012307:Risk Factors; D016036:Seroepidemiologic Studies
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G